484 related articles for article (PubMed ID: 8932281)
1. Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles.
Lobashevsky A; Kotb M; Gaber AO
Transplantation; 1996 Nov; 62(9):1332-40. PubMed ID: 8932281
[TBL] [Abstract][Full Text] [Related]
2. Restrictions in the repertoire of allospecific T cells. Contribution of the alpha-helical sequence polymorphism of HLA-DR molecules.
Goronzy JJ; Xie C; Hu W; Lundy SK; Weyand CM
J Immunol; 1993 Jul; 151(2):825-36. PubMed ID: 8335912
[TBL] [Abstract][Full Text] [Related]
3. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
4. The T-cell receptor V beta 6 gene usage in alloreactive T-cell responses.
Hu W; Weyand CM; Goronzy JJ
Hum Immunol; 1995 Jan; 42(1):72-80. PubMed ID: 7751162
[TBL] [Abstract][Full Text] [Related]
5. T-cell receptor beta-chain usage in directly activated alloreactive CD4+ T cells: unrestricted Vbeta gene usage with CDR3 size limitations.
Zhai Y; Kupiec-Weglinski JW
Transplantation; 2003 Feb; 75(4):514-21. PubMed ID: 12605120
[TBL] [Abstract][Full Text] [Related]
6. Selection of T cell receptor V beta elements by HLA-DR determinants predisposing to rheumatoid arthritis.
Weyand CM; Oppitz U; Hicok K; Goronzy JJ
Arthritis Rheum; 1992 Sep; 35(9):990-8. PubMed ID: 1384516
[TBL] [Abstract][Full Text] [Related]
7. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients.
Navaneetham D; Penn AS; Howard JF; Conti-Fine BM
J Autoimmun; 1998 Dec; 11(6):621-33. PubMed ID: 9878084
[TBL] [Abstract][Full Text] [Related]
8. Direct recognition of foreign MHC determinants by naive T cells mobilizes specific Vbeta families without skewing of the complementarity-determining region 3 length distribution.
Sebille F; Gagne K; Guillet M; Degauque N; Pallier A; Brouard S; Vanhove B; Delsuc MA; Soulillou JP
J Immunol; 2001 Sep; 167(6):3082-8. PubMed ID: 11544292
[TBL] [Abstract][Full Text] [Related]
9. Biased T-cell receptor usage is associated with allelic variation in the MHC class II peptide binding groove.
Yassine-Diab B; Carmichael P; L'Faqihi FE; Lombardi G; Deacock S; de Préval C; Coppin H; Lechler RI
Immunogenetics; 1999 Jun; 49(6):532-40. PubMed ID: 10380698
[TBL] [Abstract][Full Text] [Related]
10. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition.
Boitel B; Ermonval M; Panina-Bordignon P; Mariuzza RA; Lanzavecchia A; Acuto O
J Exp Med; 1992 Mar; 175(3):765-77. PubMed ID: 1371303
[TBL] [Abstract][Full Text] [Related]
11. The TCR Vbeta signature of bacterial superantigens spreads with stimulus strength.
Llewelyn M; Sriskandan S; Terrazzini N; Cohen J; Altmann DM
Int Immunol; 2006 Oct; 18(10):1433-41. PubMed ID: 16893924
[TBL] [Abstract][Full Text] [Related]
12. TCR Vβ Usage of Peripheral Blood and Liver Infiltrating Lymphocytes in Patients with Chronic Hepatitis B.
Zhou J; Kong C; Ban B; Dong H; Jin C
Ann Hepatol; 2018 Mar; 17(2):214-222. PubMed ID: 29469044
[TBL] [Abstract][Full Text] [Related]
13. Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E.
Li J; Goldstein I; Glickman-Nir E; Jiang H; Chess L
J Immunol; 2001 Oct; 167(7):3800-8. PubMed ID: 11564797
[TBL] [Abstract][Full Text] [Related]
14. Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific alphabeta+ T cell clones.
Zanni MP; von Greyerz S; Schnyder B; Wendland T; Pichler WJ
Int Immunol; 1998 Apr; 10(4):507-15. PubMed ID: 9620607
[TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1 molecules and antigenic experience shape the repertoire of CD4 T cells.
Walser-Kuntz DR; Weyand CM; Fulbright JW; Moore SB; Goronzy JJ
Hum Immunol; 1995 Dec; 44(4):203-9. PubMed ID: 8770633
[TBL] [Abstract][Full Text] [Related]
16. Allorecognition and T cell repertoire selection in severe combined immunodeficiency lacking HLA class II antigens.
Knobloch C; Ballas M; Wölpl A; Friedrich W
Transplantation; 1992 Jun; 53(6):1295-301. PubMed ID: 1534939
[TBL] [Abstract][Full Text] [Related]
17. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
[TBL] [Abstract][Full Text] [Related]
18. T cell receptor Vbeta repertoire usage and clonal expansion of T cells in chronic myelogenous leukemia.
Li YQ; Yang LJ; Chen SH; Zhang YP; Zhang XL; Luo GX
Chin Med J (Engl); 2004 Jun; 117(6):840-3. PubMed ID: 15198883
[TBL] [Abstract][Full Text] [Related]
19. Biased TCR gene usage in alloreactive T cells specific for a structurally dissimilar MHC alloantigen.
George A; Dazzi F; Lynch J; Sidhu S; Marelli F; Batchelor RJ; Lombardi G; Lechler RI
Int Immunol; 1994 Nov; 6(11):1785-90. PubMed ID: 7865471
[TBL] [Abstract][Full Text] [Related]
20. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.
Jones CM; Lake RA; Lamb JR; Faith A
Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
